Tokyo, March 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060835) titled 'A study comparing the required doses of two sedatives, Remimazolam and Propofol, in patients undergoing gastric endoscopy' on March 5.
Study Type:
Observational
Primary Sponsor:
Institute - Public Interest Incorporated Foundation Sendai City Medical Center, Sendai, Japan.
Condition:
Condition - Patients undergoing esophagogastroduodenoscopy (EGD) for screening or diagnostic purposes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - 1: To calculate the clinical equipotent dose ratio of Remimazolam (RMZ) to Propofol (PRO) in the same patients under opioid-free conditi...